Hera Health Solutions has raised $1.3M in seed funding from Innova. The company is building a nanotechnology-based drug delivery platform designed to let a single dose of a drug keep working for months, with fewer side effects. Its system is biodegradable and versatile enough to deliver active ingredients through implants, pellets, and patches, with the company claiming effects lasting up to 48 months. The pitch to pharma companies: turn promising APIs into long-acting, precise therapeutics.













